

> 定義


# URINARY TRACT INFECTIONS

定義

• **Uncomplicated:** confined to bladder (cystitis) or urethra. No signs and symptoms systemic infection.

• **Complicated:** extends beyond bladder with signs and symptoms incl. fever, rigors, malaise, flank pain, CVA tenderness, or pelvic/perineal pain in male. Includes pyelonephritis (inflam of renal parenchyma), perinephric abscess, prostatitis. Immunocompromised, men, poorly controlled DM, or those with urologic 異常 (nephrolith., strictures, stents, diversions) are not automatically complicated, but at high risk. Follow closely with low threshold to escalate Rx. Pregnant & renal Tx _are_ complicated.

Microbiology

• Uncomplicated: **_E. coli_** (80%), _Proteus_, _Klebsiella_, _S. saprophyticus_ (_CID_ 2004;39:75). In healthy, nonpregnant women, lactobacilli, enterococci, Group B strep and coag-neg staph (except _S. saprophyticus_) are likely _contaminants_ (_Annals_ 2012;156:ITC3).

• Complicated: as above + PsA, enterococci, staph (uncommon 1º urinary pathogen without catheter or recent instrumentation; ? bacteremia with hematogenous spread). ↑ MDR.

• Catheter-associated: _E. coli_ most prevalent, but high risk for yeast (24%), MDR PsA, _Klebs_, _Enterococcus_

• Urethritis: _Chlamydia trachomatis, Neisseria gonorrhoeae, Ureaplasma urealyticum, Trichomonas vaginalis, Mycoplasma genitalium_, HSV

臨床表現

• **Cystitis: dysuria**, **urgency**, **frequency**, hematuria, suprapubic pain; fever _absent._ 排除 vaginitis if symptoms of cystitis & urethritis. Neurogenic bladder 病人 may have atypical sx (↑ spasticity, autonomic dysreflexia, malaise).

• **Urethritis:** similar to cystitis except _urethral discharge_ can be present

• **Prostatitis:** chronic: similar to cystitis except _symptoms of obstruction_ (hesitancy, weak stream); acute: perineal pain, fever, tenderness on prostate exam

• **Pyelonephritis:** fever, chills, flank or back pain, nausea, vomiting, diarrhea

• **Renal abscess** (intrarenal, perinephric): identical to pyelonephritis with _persistent fever despite appropriate antibiotics_

Diagnostic studies (_NEJM_ 2016;374:562)

• **Urinalysis: pyuria** + bacteriuria ± hematuria ± nitrites

• **Urine Cx** (clean-catch midstream or straight-cath)

Obtain cx only if symptoms (although in ill 病人, can include ΔMS, autonomic instability)

⊕ if: ≥105 CFU/mL in women, ≥103 CFU/mL in men. Counts may vary depending on dilution & stage of infxn; interpret in context of sx and host.

Pyuria & ⊖ UCx = sterile pyuria → urethritis, nephritis, renal tuberculosis, foreign body

• **Catheter-associated:** requires (1) signs and symptoms (incl atypical) + (2) urine Cx with 1 species ≥103 colonies from clean urine sample (after replacing Foley). Pyuria alone _not_ sufficient to dx UTI in this setting (may be colonization, do not Rx or screen for asx bacteruria).

• Blood cultures: obtain in febrile 病人; consider in complicated UTIs

• For all men with UTI, consider prostatitis: ✔ prostate exam; UCx including 1st void, midstream, and ideally prostatic expressage & postprostatic massage UCx

• Abdominal CT: 排除 abscess in 病人 with pyelo who fail to defervesce after 72 h

• Urologic workup (renal U/S with PVR, abd CT, voiding cystography) if recurrent UTIs in men

<table><colgroup><col> <col></colgroup><tbody><tr><td colspan="2"><p><b>治療 of UTIs</b> <span>(</span><span><i>CID</i></span> <span>20</span><span>1</span><span>0;50:625;</span> <span><i>JAMA</i></span> <span>20</span><span>1</span><span>4;3</span><span>1</span><span>2:</span><span>1</span><span>677)</span></p></td></tr><tr><td><p><b>Scenario</b></p></td><td><p><b>Empiric 治療 Guidelines</b> (choice can be individualized)</p></td></tr><tr><td><p><b>Cystitis</b> <span><i>(JAMA</i></span> <span>20</span><span>1</span><span>4;</span><span>1</span><span>6:</span><span>1</span><span>677)</span></p></td><td><p>Uncomp: nitrofurantoin 100 mg × 5 d <i>or</i> TMP-SMX DS PO × 3 d <i>or</i> fosfomycin (3 g × 1). Refer to dosing guidelines for ↑ Cr.</p><p>Complicated: FQ or TMP-SMX PO × 7–14 d</p><p>FQ or TMP-SMX superior to β-lactams <span>(</span><span><i>NEJM</i></span> <span>20</span><span>1</span><span>2;366:</span><span>1</span><span>028)</span></p><p>Asx bacteriuria in pregnancy or prior to urologic surgery → 抗生素 × 3 d</p></td></tr><tr><td><p><b>Catheterized</b></p></td><td><p>Await cultures if HD stable &amp; <b>remove (or exchange) catheter</b></p></td></tr><tr><td><p><b>Urethritis</b></p></td><td><p>Treat for both <i>Neisseria</i> and <i>Chlamydia</i></p><p><i>Neisseria:</i> CTX 250 mg IM × 1 and 1 g azithro PO × 1</p><p><i>Chlamydia:</i> doxy 100 mg PO bid × 7 d <i>or</i> azithro 1 g PO × 1</p><p><i>M. genitalium:</i> 1 g azithro PO × 1</p></td></tr><tr><td><p><b>Prostatitis</b></p></td><td><p>FQ or TMP-SMX PO × 14–28 d (acute) or 6–12 wk (chronic)</p></td></tr><tr><td><p><b>Pyelonephritis</b></p></td><td><p>OutPt: FQ × 7 d <i>or</i> TMP-SMX PO × 14 d <span>(</span><span><i>Lancet</i></span> <span>20</span><span>1</span><span>2;380:452)</span></p><p>InPt: CTX <i>or</i> aminoglycoside × 14 d; if at risk for MDR pathogen cefepime, pip-tazo, carbapenem, or plazomicin <span>(</span><span><i>NEJM</i></span> <span>20</span><span>1</span><span>9;380:729)</span></p><p>(Δ IV → PO when clinically improved &amp; afebrile 24–48 h, tailor to Cx)</p></td></tr><tr><td><p><b>Renal abscess</b></p></td><td><p>Drainage + antibiotics as for pyelonephritis</p></td></tr></tbody></table>
